Post-authorisation

  • Email
  • Help

The European Medicines Agency (EMA) provides scientific and regulatory guidance to pharmaceutical companies whose medicinal products have been authorised in Europe. This is known as the post-authorisation stage of the product lifecycle. 

This sets out the responsibilities of marketing authorisation holders in areas such as pharmacovigilance, applying to vary a marketing authorisation, submitting product data to EMA and reporting product defects or recalls.  

In this section

 

How helpful is this page?

Average rating:

 Based on 9 ratings

Add your rating:

See all ratings
2 ratings
1 ratings
0 ratings
0 ratings
6 ratings
    

Tell us more

Related content